Current market catalysts

Evommune Reveals Top-Line Results From EVO756 Phase 2b Trial In Moderate-To-Severe Atopic Dermatitis; Says Trial Did Not Meet The Primary Endpoint Of Percent Change In Eczema Area And Severity Index Score From Baseline At Week 12; EVO756 Was Generally Well Tolerated; To Continue Phase 2b Development Of EVO756 In Migraine Prophylaxis; Will Not Advance EVO756 In Atopic Dermatitis

Here's How Much $100 Invested In Linde 10 Years Ago Would Be Worth Today

Linde (NASDAQ:LIN) has outperformed the market over the past 10 years by 1.14% on an annualized basis producing an average annual return of 14.78%. Currently, Linde has a market capitalization of $217.97 billion.

8-K filing — TELEFLEX INC (TFX)

Filed: 2026-09-09 AccNo: 0000096943-26-000101 Size: 174 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Buyout Debt Is Surging to Levels Not Seen Since Before the Financial Crisis

Bankers are looking to sell off approximately $138 billion of buyout debt in the coming months, according to JPMorgan.

8-K filing — X4 Pharmaceuticals, Inc (XFOR)

Filed: 2026-09-09 AccNo: 0001501697-26-000076 Size: 2 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — Bit Digital, Inc (BTBT)

Filed: 2026-09-09 AccNo: 0001213900-26-098132 Size: 18 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

If You Invested $1000 In Royalty Pharma Stock 15 Years Ago, You Would Have This Much Today

Royalty Pharma (NASDAQ:RPRX) has outperformed the market over the past 15 years by 4.89% on an annualized basis producing an average annual return of 18.08%. Currently, Royalty Pharma has a market capitalization of

'Blackstone’s Head of Real Estate Is Leaving the Firm'- WSJ

QUICK SPARK: LIV Golf’s $1 Billion Debt Problem Triggers Bankruptcy Filing

LIV Golf’s push to bring outside investors into its teams has taken on new urgency after the league filed for Chapter 11 bankruptcy.

8-K filing — Sound Point Meridian Capital, Inc. (SPMA)

Filed: 2026-09-08 AccNo: 0001829126-26-009903 Size: 253 KB Item 8.01: Other Events

8-K/A filing — Vivos Therapeutics, Inc. (VVOS)

Filed: 2026-09-08 AccNo: 0001493152-26-041807 Size: 241 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

8-K filing — Ellington Credit Co (ELLA)

Filed: 2026-09-08 AccNo: 0001628280-26-060947 Size: 179 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — Chime Financial, Inc. (CHYM)

Filed: 2026-09-08 AccNo: 0001193125-26-385383 Size: 776 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — Ellington Financial Inc. (EFC-PC)

Filed: 2026-09-08 AccNo: 0001628280-26-060946 Size: 211 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — MURPHY OIL CORP (MUR)

Filed: 2026-09-08 AccNo: 0000950103-26-013671 Size: 13 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — Ocugen, Inc. (OCGN)

Filed: 2026-09-08 AccNo: 0001104659-26-105968 Size: 5 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — REPLIGEN CORP (RGEN)

Filed: 2026-09-08 AccNo: 0001193125-26-385380 Size: 151 KB Item 8.01: Other Events

8-K filing — Nerdy Inc. (NRDY)

Filed: 2026-09-08 AccNo: 0001819404-26-000097 Size: 173 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

8-K filing — Estrella Immunopharma, Inc. (ESLAW)

Filed: 2026-09-08 AccNo: 0001213900-26-098123 Size: 242 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Milestone Scientific Files Prospectus To Offer Securities Up To $45M

Casey's General Stores Stock Tumbles After Q1 Earnings

Caseys General Stores Inc (NASDAQ:CASY) shares are moving lower in extended trading Tuesday on the heels of the company's first-quarter results.

8-K filing — Hepion Pharmaceuticals, Inc. (CTRVP)

Filed: 2026-09-08 AccNo: 0001493152-26-041801 Size: 945 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

8-K filing — Stimcell Energetics Inc. (STME)

Filed: 2026-09-08 AccNo: 0001493712-26-000012 Size: 207 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — Worthington Steel, Inc. (WS)

Filed: 2026-09-08 AccNo: 0001193125-26-385371 Size: 283 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — CONSTELLATION BRANDS, INC. (STZ)

Filed: 2026-09-08 AccNo: 0000016918-26-000034 Size: 597 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

JIN MEDICAL INTERNATIONAL Says Will Obtain Contractual Control Over, Right To Receive Substantially All Economic Benefits Of, Huaxia Qiying Through VIE Agreements; Co, Erhua Med Will Not Acquire Legal Title To Equity Interests Of Chenglan Kangxu Or Huaxia Qiying Solely As A Result Of VIE Agreements; Agreement Provides For Aggregate Consideration Of $159.4M For Integrated Transaction

$1000 Invested In AMETEK 15 Years Ago Would Be Worth This Much Today

AMETEK (NYSE:AME) has outperformed the market over the past 15 years by 2.87% on an annualized basis producing an average annual return of 16.06%. Currently, AMETEK has a market capitalization of $54.50 billion. Buying

8-K filing — 5C Lending Partners Corp.

Filed: 2026-09-08 AccNo: 0000930413-26-002858 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits

8-K filing — FREEPORT-MCMORAN INC (FCX)

Filed: 2026-09-08 AccNo: 0000831259-26-000038 Size: 143 KB Item 8.01: Other Events

8-K filing — Perspective Therapeutics, Inc. (CATX)

Filed: 2026-09-08 AccNo: 0001193125-26-385362 Size: 24 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits